Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methods and rationale of the DISCOVER CKD global observational study
Roberto Pecoits–Filho, Glen James, Juan Jesús Carrero, et al.
Clinical Kidney Journal (2021) Vol. 14, Iss. 6, pp. 1570-1578
Open Access | Times Cited: 21

Showing 21 citing articles:

Projecting the economic burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study
Steven J. Chadban, Mustafa Arıcı, Albert Power, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102615-102615
Open Access | Times Cited: 13
Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study
Glenn M. Chertow, Ricardo Correa‐Rotter, Kai‐Uwe Eckardt, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102614-102614
Open Access | Times Cited: 12
Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD
Navdeep Tangri, Steven J. Chadban, Claudia Cabrera, et al.
Advances in Therapy (2022) Vol. 40, Iss. 1, pp. 265-281
Open Access | Times Cited: 23
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility
Glen James, Juan José García Sánchez, Juan Jesús Carrero, et al.
Kidney International Reports (2022) Vol. 7, Iss. 9, pp. 2059-2070
Open Access | Times Cited: 19
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort
Juan José García Sánchez, Glen James, Juan Jesús Carrero, et al.
Kidney International Reports (2023) Vol. 8, Iss. 4, pp. 785-795
Open Access | Times Cited: 11
Inside CKD: Cost-effectiveness of multinational screening for chronic kidney disease
Navdeep Tangri, Kook‐Hwan Oh, Jason Choo, et al.
Kidney International Reports (2025)
Open Access
Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort
Carol A. Pollock, Glen James, Juan José García Sánchez, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 11, pp. 2124-2134
Open Access | Times Cited: 13
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Oliver Schnell, Tadej Battelino, Richard M. Bergenstal, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort
Hiddo J.L. Heerspink, Stephen Nolan, Juan Jesús Carrero, et al.
Advances in Therapy (2024) Vol. 41, Iss. 8, pp. 3264-3277
Open Access | Times Cited: 2
IMPACT CKD: Holistic disease model projecting 10-year population burdens
Stephen Brown, Juan José García Sánchez, Hannah Guiang, et al.
Kidney International Reports (2024) Vol. 9, Iss. 11, pp. 3156-3166
Open Access | Times Cited: 2
Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort
Carol A. Pollock, Glen James, Juan José García Sánchez, et al.
Advances in Therapy (2022) Vol. 39, Iss. 3, pp. 1432-1445
Open Access | Times Cited: 9
Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data
Dustin J. Little, Matthew Arnold, Katarina Hedman, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Projecting the population level burden of CKD progression according to urine albumin-to-creatinine ratio categories
Luca De Nicola, Ricardo Correa-Rotter, Juan F. Navarro‐González, et al.
Kidney International Reports (2024) Vol. 9, Iss. 12, pp. 3464-3476
Open Access | Times Cited: 1
Inside CKD: a microsimulation modelling study projects the clinical and economic burden of chronic kidney disease in Hungary
Lilla Szabó, Luca Adél Halmai, Erzsébet Ladányi, et al.
Frontiers in Nephrology (2024) Vol. 4
Open Access | Times Cited: 1
Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
Kerstin Folkerts, A. Millier, B. Smela, et al.
Journal of Nephrology (2022) Vol. 36, Iss. 4, pp. 1135-1167
Open Access | Times Cited: 4
Developing a common data model approach for DISCOVER CKD: A retrospective, global cohort of real-world patients with chronic kidney disease
Supriya Kumar, Matthew Arnold, Glen James, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274131-e0274131
Open Access | Times Cited: 3
Proyección de la carga clínica y económica de la enfermedad renal crónica entre 2022 y 2027 en España: resultados del proyecto Inside CKD
Juan F. Navarro‐González, Alberto Ortíz, Ana Cebrián Cuenca, et al.
Nefrología (2024) Vol. 44, Iss. 6, pp. 807-817
Open Access
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort
Steven Fishbane, Juan Jesús Carrero, Supriya Kumar, et al.
Kidney360 (2024) Vol. 5, Iss. 7, pp. 974-986
Open Access
Baseline Characteristics of the DISCOVER CKD Prospective Cohort
Carol A. Pollock, Juan Jesús Carrero, Eiichiro Kanda, et al.
Advances in Therapy (2024)
Closed Access
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project
Juan F. Navarro‐González, Alberto Ortíz, Ana Cebrián Cuenca, et al.
Nefrología (English Edition) (2024) Vol. 44, Iss. 6, pp. 807-817
Open Access
Glucose‐lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification
Carol A. Pollock, Juan José García Sánchez, Juan Jesús Carrero, et al.
Diabetic Medicine (2023)
Open Access
Page 1

Scroll to top